CCL2 and neoplasm: This signaling pathway also recruits neutrophils and macrophages via MCP-1 secretion, promotes M2 macrophage polarization, inhibits dendritic cell activation, and enhances Treg differentiation, contributing to an immunosuppressive TME that supports tumor progression 54-58.